Ferritin Dynamics are Associated with Clinical Outcomes of Multiple Myeloma Patients Receiving Bispecific Antibodies

被引：0
|
作者：
Mouhieddine, Tarek [1 ]
Sheng, Tianxiang [2 ]
Costa, Bruno [1 ]
Saffran, Nathaniel [1 ]
Pan, Darren [3 ]
Thibaud, Santiago [1 ]
Sanchez, Larysa [1 ]
Richard, Shambavi [1 ]
Rossi, Adriana [1 ]
Cho, Hearn Jay [4 ]
Richter, Joshua [1 ]
Rodriguez-Valdes, Cesar [1 ]
Chari, Ajai [5 ]
Parekh, Samir [4 ]
Moshier, Erin
Jagannath, Sundar [6 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Mt Sinai Hosp, New York, NY USA
[3] Mt Sinai, New York, NY USA
[4] Icahn Sch Med Mt Sinai, Precis Immunol Inst, Multiple Myeloma Ctr Excellence, Tisch Canc Ctr, New York, NY USA
[5] Univ Calif San Francisco, San Francisco, CA USA
[6] Mt Sinai Med Ctr, New York, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-059
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [21] Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib
    Ariana Berenson
    Suzie Vardanyan
    Michael David
    James Wang
    Nika Manik Harutyunyan
    Jillian Gottlieb
    Ran Halleluyan
    Tanya M. Spektor
    Kyle A. Udd
    Shahrooz Eshaghian
    Youram Nassir
    Benjamin Eades
    Regina Swift
    James R. Berenson
    Annals of Hematology, 2017, 96 : 449 - 459
  • [22] Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib
    Berenson, Ariana
    Vardanyan, Suzie
    David, Michael
    Wang, James
    Harutyunyan, Nika Manik
    Gottlieb, Jillian
    Halleluyan, Ran
    Spektor, Tanya M.
    Udd, Kyle A.
    Eshaghian, Shahrooz
    Nassir, Youram
    Eades, Benjamin
    Swift, Regina
    Berenson, James R.
    ANNALS OF HEMATOLOGY, 2017, 96 (03) : 449 - 459
  • [23] Prophylactic Dexamethasone and Remote Monitoring for Patients with Relapsed Refractory Multiple Myeloma (RRMM) Receiving Bispecific Antibodies (BsAb): Experience at a Single Institution
    Varga, Cindy
    Ahmed, Ferdous
    Knight, Marvin
    Bhutani, Manisha
    Paul, Barry
    Atrash, Shebli
    Voorhees, Peter M.
    Ferreri, Christopher
    BLOOD, 2024, 144 : 4720 - 4721
  • [24] Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma
    Dalla Palma, Benedetta
    Marchica, Valentina
    Catarozzo, Maria Teresa
    Giuliani, Nicola
    Accardi, Fabrizio
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 11
  • [25] T-CELL BISPECIFIC ANTIBODIES SUPPRESS MULTIPLE MYELOMA
    Seckinger, A.
    Delgado, J. A.
    Moser, S.
    Moreno, L.
    Neuber, B.
    Grab, A.
    Li, J.
    Stagg, N. J.
    Johnston, J.
    Harris, M. J.
    Menzies, S. A.
    DiCara, D.
    CANCER DISCOVERY, 2017, 7 (05) : 452 - 452
  • [26] Balancing the Scales: Optimizing Reporting of Infection Rates in Clinical Trials of Bispecific Antibodies in Multiple Myeloma
    Richter, Joshua
    Dhodapkar, Madhav V.
    Li, Mengying
    Awad, Mina
    Hampp, Christian
    Knorr, Kate
    Kroog, Glenn
    Roccia, Tito
    Bumma, Naresh
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (04) : 548 - 551
  • [27] Immune Dynamics Associated with Patient Outcomes Identified By Multimodal Single-Cell Analysis in Multiple Myeloma Patients Receiving Talquetamab Monotherapy
    Mouhieddine, Tarek H.
    dos Santos, Junia Vieira
    Ghodke-Puranik, Yogita
    Aleman, Adolfo
    Melnekoff, David
    Upadhyaya, Bhaskar
    Rahman, Adeeb
    Afik, Shaked
    Lewinsky, Hadas
    Thibaud, Santiago
    Rossi, Adriana C.
    Richard, Shambavi
    Rodriguez, Cesar
    Richter, Joshua
    Cho, Hearn Jay
    Sanchez, Larysa
    Jagannath, Sundar
    Chari, Ajai
    Lagana, Alessandro
    Parekh, Samir
    BLOOD, 2023, 142
  • [28] Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies
    Taku Kikuchi
    Nobuhiro Tsukada
    Kodai Kunisada
    Moe Nomura-Yogo
    Yuki Oda
    Kota Sato
    Tomomi Takei
    Mizuki Ogura
    Yu Abe
    Kenshi Suzuki
    Tadao Ishida
    Annals of Hematology, 2023, 102 : 3489 - 3497
  • [29] Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies
    Kikuchi, Taku
    Tsukada, Nobuhiro
    Kunisada, Kodai
    Nomura-Yogo, Moe
    Oda, Yuki
    Sato, Kota
    Takei, Tomomi
    Ogura, Mizuki
    Abe, Yu
    Suzuki, Kenshi
    Ishida, Tadao
    ANNALS OF HEMATOLOGY, 2023, 102 (12) : 3489 - 3497
  • [30] Treatment patterns for extramedullary multiple myeloma and outcomes with CAR-T therapy and bispecific antibodies.
    Zanwar, Saurabh
    Ho, Matthew
    Kapoor, Prashant
    Binder, Moritz
    Buadi, Francis
    Dispenzieri, Angela
    Dingli, David
    Fonder, Amie L.
    Gertz, Morie A.
    Gonsalves, Wilson I.
    Hayman, Suzanne R.
    Hwa, Yi Lisa
    Hobbs, Miriam A.
    Kourelis, Taxiarchis
    Lacy, Martha
    Leung, Nelson
    Muchtar, Eli
    Warsame, Rahma M.
    Rajkumar, S. Vincent
    Kumar, Shaji
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345